Current investors

Our current investors are a group of specialist international deep tech investors.

Register for investor news

Data Consent *
Click a dot to pause scrolling

UK Innovation & Science Seed Fund (UKI2S)

UKI2S is a national seed capital fund backed by UKRI, Dstl and other public bodies that nurtures innovative businesses from great UK science to leverage private investment and grow jobs.

The Fund provides patient, long-term committed capital and strategic advice to help these companies flourish. Over the past decade and more, the fund has built a substantial track record of companies that between them have attracted over £600m of later stage investment.

Learn more

Twitter: @UKI2S

UK CPI

CPI works with partners to translate inventions into products and processes that enhance health and wellbeing, protect and improve our environment and increase productivity across industries.

With a deep understanding of technology foresighting, innovation processes and funding, outstanding technical expertise and industry-relevant assets, we enable the accelerated development of transformational products and processes that have the potential to disrupt and revolutionise markets. We also engage in incremental technological innovation that allows established products and processes to be optimised for better performance and efficient manufacture.

Through the breadth of our technology platforms, we support our partners across many diverse markets, including pharmaceuticals, speciality chemicals, food and drink, electronics and transportation.

www.uk-cpi.com

SOSV

SOSV is a global venture capital firm that operates early stage startup development programs: HAX (Newark/San Francisco/Shenzhen/Tokyo) for hardware, IndieBio (San Francisco/NYC) for life sciences, Chinaccelerator (Shanghai) and MOX (Taipei) for cross-border internet, and dlab (NYC) for blockchain.

The five programs work with 135 new companies each year. As of January 2022, SOSV had more than 1,000 portfolio companies and $1B billion in assets under management.

Chrysalix Venture Capital

Chrysalix is a technology focused venture capital firm that builds, mentors and connects high growth companies. Founded in Vancouver, Canada in 2001, and with offices also in Delft, Netherlands, Chrysalix has built its reputation on bringing disruptive innovation to the world’s largest industries by focusing on where technology meets physical science.

The firm’s investments include breakthrough technologies like smart mining, 3D printing of steel, fast charging electric vehicle infrastructure, battery intelligence, CO2 capture, wastewater management, and fusion energy. Chrysalix has one of the strongest investment teams in the industry with deep energy, industrial technology and entrepreneurial expertise, and is backed by more than 20 international blue-chip industrial and financial investors. Chrysalix latest fund, the Chrysalix RoboValley Fund, is the firm’s second fund under management focused on industrial innovation.

For more information visit: www.chrysalix.com

UK Innovation & Science Seed Fund (UKI2S)

UKI2S is a national seed capital fund backed by UKRI, Dstl and other public bodies that nurtures innovative businesses from great UK science to leverage private investment and grow jobs.

The Fund provides patient, long-term committed capital and strategic advice to help these companies flourish. Over the past decade and more, the fund has built a substantial track record of companies that between them have attracted over £600m of later stage investment.

Learn more

Twitter: @UKI2S

UK CPI

CPI works with partners to translate inventions into products and processes that enhance health and wellbeing, protect and improve our environment and increase productivity across industries.

With a deep understanding of technology foresighting, innovation processes and funding, outstanding technical expertise and industry-relevant assets, we enable the accelerated development of transformational products and processes that have the potential to disrupt and revolutionise markets. We also engage in incremental technological innovation that allows established products and processes to be optimised for better performance and efficient manufacture.

Through the breadth of our technology platforms, we support our partners across many diverse markets, including pharmaceuticals, speciality chemicals, food and drink, electronics and transportation.

www.uk-cpi.com

SOSV

SOSV is a global venture capital firm that operates early stage startup development programs: HAX (Newark/San Francisco/Shenzhen/Tokyo) for hardware, IndieBio (San Francisco/NYC) for life sciences, Chinaccelerator (Shanghai) and MOX (Taipei) for cross-border internet, and dlab (NYC) for blockchain.

The five programs work with 135 new companies each year. As of January 2022, SOSV had more than 1,000 portfolio companies and $1B billion in assets under management.

Chrysalix Venture Capital

Chrysalix is a technology focused venture capital firm that builds, mentors and connects high growth companies. Founded in Vancouver, Canada in 2001, and with offices also in Delft, Netherlands, Chrysalix has built its reputation on bringing disruptive innovation to the world’s largest industries by focusing on where technology meets physical science.

The firm’s investments include breakthrough technologies like smart mining, 3D printing of steel, fast charging electric vehicle infrastructure, battery intelligence, CO2 capture, wastewater management, and fusion energy. Chrysalix has one of the strongest investment teams in the industry with deep energy, industrial technology and entrepreneurial expertise, and is backed by more than 20 international blue-chip industrial and financial investors. Chrysalix latest fund, the Chrysalix RoboValley Fund, is the firm’s second fund under management focused on industrial innovation.

For more information visit: www.chrysalix.com

Register for investor news

Data Consent *